Impact Health is a mission-driven health policy and strategic consulting firm dedicated to improving health and well-being for all.
OUR SERVICES
Strategic Planning
Integrate mission-aligned policy expertise and political acumen into planning and executing your goals.
Government Contracting
Track record of success supporting states and municipalities in innovating or launching new programs.
Our proprietary method for tracking, aggregating, and analyzing state policy trends.
If you believe that every American deserves to be healthy and well, contact Impact Health Policy Partners to learn how our expertise can help you achieve your goals.
Policy Hub, managed by Impact Health Policy Partners, is the only comprehensive database of Federal health policy developments, cataloged by over 200 healthcare topics and programs. Regulations, reimbursement, grants, ACA implementation, hearing summaries, CRS Reports, pending legislation – you get it all here, with comprehensive, expert analysis.
Bipartisan Doctors Not AI Act Introduced
Reps. Greg Landsman (D-OH), Buddy Carter (R-GA), Kim Schrier (D-WA) and Tom Barrett (R-MI) introduced the Doctors Not AI Act, which aims to ensure that health care professionals, not artificial intelligence (AI) are responsible for benefit determinations under group health plans and health insurance issuers offering group or individual health insurance coverage (press release). Specifically, the bill requires group health… (Slifer, September 1, 2026) #Coverage Decisions
President Trump Announces Nine Additional MFN Agreements Bringing the Total to 26 MFN Agreements
President Trump announced that nine additional pharmaceutical manufacturers have agreed to most favored nation (MFN) pricing agreements. These companies include Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB. During the press conference, President Trump once again called upon Congress to codify the MFN agreements so that they may remain permanent under future presidencies…. (Slifer, August 31, 2026) #Drug Pricing, #Prescription Drugs



